These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 19097106)

  • 1. Contrast agent dose effects in cerebral dynamic susceptibility contrast magnetic resonance perfusion imaging.
    Alger JR; Schaewe TJ; Lai TC; Frew AJ; Vespa PM; Etchepare M; Liebeskind DS; Saver JL; Kidwell SC
    J Magn Reson Imaging; 2009 Jan; 29(1):52-64. PubMed ID: 19097106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three-dimensional dynamic susceptibility-weighted perfusion MR imaging at 3.0 T: feasibility and contrast agent dose.
    Manka C; Träber F; Gieseke J; Schild HH; Kuhl CK
    Radiology; 2005 Mar; 234(3):869-77. PubMed ID: 15665227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of quantitative dynamic susceptibility-contrast MRI perfusion estimates obtained using different contrast-agent administration schemes at 3T.
    Wirestam R; Thilmann O; Knutsson L; Björkman-Burtscher IM; Larsson EM; Ståhlberg F
    Eur J Radiol; 2010 Jul; 75(1):e86-91. PubMed ID: 19720489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic susceptibility contrast MRI with a prebolus contrast agent administration design for improved absolute quantification of perfusion.
    Knutsson L; Lindgren E; Ahlgren A; van Osch MJ; Bloch KM; Surova Y; Ståhlberg F; van Westen D; Wirestam R
    Magn Reson Med; 2014 Oct; 72(4):996-1006. PubMed ID: 24285621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional and voxel-wise comparisons of blood flow measurements between dynamic susceptibility contrast magnetic resonance imaging (DSC-MRI) and arterial spin labeling (ASL) in brain tumors.
    White CM; Pope WB; Zaw T; Qiao J; Naeini KM; Lai A; Nghiemphu PL; Wang JJ; Cloughesy TF; Ellingson BM
    J Neuroimaging; 2014; 24(1):23-30. PubMed ID: 22672084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of a simplified spin and gradient echo (sSAGE) approach for human brain tumor perfusion imaging.
    Stokes AM; Skinner JT; Yankeelov T; Quarles CC
    Magn Reson Imaging; 2016 Nov; 34(9):1248-1255. PubMed ID: 27457801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identifying systematic errors in quantitative dynamic-susceptibility contrast perfusion imaging by high-resolution multi-echo parallel EPI.
    Jochimsen TH; Newbould RD; Skare ST; Clayton DB; Albers GW; Moseley ME; Bammer R
    NMR Biomed; 2007 Jun; 20(4):429-38. PubMed ID: 17044140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing perfusion metrics obtained from a single compartment versus pharmacokinetic modeling methods using dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade.
    Law M; Young R; Babb J; Rad M; Sasaki T; Zagzag D; Johnson G
    AJNR Am J Neuroradiol; 2006 Oct; 27(9):1975-82. PubMed ID: 17032878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating quantitative approaches to dynamic susceptibility contrast MRI among carotid endarterectomy patients.
    Crane DE; Donahue MJ; Chappell MA; Sideso E; Handa A; Kennedy J; Jezzard P; MacIntosh BJ
    J Magn Reson Imaging; 2013 Apr; 37(4):936-43. PubMed ID: 23097408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of gradient- and spin-echo imaging: CBF, CBV, and MTT measurements by bolus tracking.
    Simonsen CZ; Ostergaard L; Smith DF; Vestergaard-Poulsen P; Gyldensted C
    J Magn Reson Imaging; 2000 Sep; 12(3):411-6. PubMed ID: 10992308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of regional tracer delay on CBF in healthy subjects measured with dynamic susceptibility contrast-enhanced MRI: comparison with 15O-PET.
    Ibaraki M; Shimosegawa E; Toyoshima H; Ishigame K; Ito H; Takahashi K; Miura S; Kanno I
    Magn Reson Med Sci; 2005; 4(1):27-34. PubMed ID: 16127251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CBF and CBV measurements by USPIO bolus tracking: reproducibility and comparison with Gd-based values.
    Simonsen CZ; Ostergaard L; Vestergaard-Poulsen P; Røhl L; Bjørnerud A; Gyldensted C
    J Magn Reson Imaging; 1999 Feb; 9(2):342-7. PubMed ID: 10077035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of three-dimensional pseudo-continuous arterial spin labeling perfusion imaging with gradient-echo and spin-echo dynamic susceptibility contrast MRI.
    Wong AM; Yan FX; Liu HL
    J Magn Reson Imaging; 2014 Feb; 39(2):427-33. PubMed ID: 23677620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Slice-accelerated gradient-echo echo planar imaging dynamic susceptibility contrast-enhanced MRI with blipped CAIPI: effect of increasing temporal resolution.
    Takamura T; Hori M; Kamagata K; Kumamaru KK; Irie R; Hagiwara A; Hamasaki N; Aoki S
    Jpn J Radiol; 2018 Jan; 36(1):40-50. PubMed ID: 29086345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Method for improving the accuracy of quantitative cerebral perfusion imaging.
    Sakaie KE; Shin W; Curtin KR; McCarthy RM; Cashen TA; Carroll TJ
    J Magn Reson Imaging; 2005 May; 21(5):512-9. PubMed ID: 15834910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of dexamethasone on cerebral perfusion and water diffusion in patients with high-grade glioma.
    Bastin ME; Carpenter TK; Armitage PA; Sinha S; Wardlaw JM; Whittle IR
    AJNR Am J Neuroradiol; 2006 Feb; 27(2):402-8. PubMed ID: 16484419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Whole brain quantitative CBF, CBV, and MTT measurements using MRI bolus tracking: implementation and application to data acquired from hyperacute stroke patients.
    Smith AM; Grandin CB; Duprez T; Mataigne F; Cosnard G
    J Magn Reson Imaging; 2000 Sep; 12(3):400-10. PubMed ID: 10992307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole brain quantitative CBF and CBV measurements using MRI bolus tracking: comparison of methodologies.
    Smith AM; Grandin CB; Duprez T; Mataigne F; Cosnard G
    Magn Reson Med; 2000 Apr; 43(4):559-64. PubMed ID: 10748431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantification of perfusion and permeability in multiple sclerosis: dynamic contrast-enhanced MRI in 3D at 3T.
    Ingrisch M; Sourbron S; Morhard D; Ertl-Wagner B; Kümpfel T; Hohlfeld R; Reiser M; Glaser C
    Invest Radiol; 2012 Apr; 47(4):252-8. PubMed ID: 22373532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of contrast agents with high molarity and with weak protein binding in cerebral perfusion imaging at 3 T.
    Thilmann O; Larsson EM; Björkman-Burtscher IM; Ståhlberg F; Wirestam R
    J Magn Reson Imaging; 2005 Nov; 22(5):597-604. PubMed ID: 16200539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.